Unravelling the interaction of pirenzepine, a gastrointestinal disorder drug, with calf thymus DNA: An in vitro and molecular modelling study

2017 ◽  
Vol 625-626 ◽  
pp. 1-12 ◽  
Author(s):  
Yusra Rahman ◽  
Shumaila Afrin ◽  
Mohammed Amir Husain ◽  
Tarique Sarwar ◽  
Abad Ali ◽  
...  
2017 ◽  
Vol 98 ◽  
pp. 319-328 ◽  
Author(s):  
Tarique Sarwar ◽  
Hassan Mubarak Ishqi ◽  
Sayeed Ur Rehman ◽  
Mohammed Amir Husain ◽  
Yusra Rahman ◽  
...  

RSC Advances ◽  
2018 ◽  
Vol 8 (17) ◽  
pp. 9083-9093 ◽  
Author(s):  
Mohd. Sajid Ali ◽  
Mohammad Abul Farah ◽  
Hamad A. Al-Lohedan ◽  
Khalid Mashay Al-Anazi

DNA demethylating agent procaine binds at the minor groove of ct-DNA and increases the anticancer activity of doxorubicin.


2017 ◽  
Vol 97 ◽  
pp. 392-402 ◽  
Author(s):  
Faizan Abul Qais ◽  
K.M. Abdullah ◽  
Md. Maroof Alam ◽  
Imrana Naseem ◽  
Iqbal Ahmad

2019 ◽  
Vol 34 (1) ◽  
pp. 1247-1258 ◽  
Author(s):  
Asmaa F. Kassem ◽  
Gaber O. Moustafa ◽  
Eman S. Nossier ◽  
Hemat S. Khalaf ◽  
Marwa M. Mounier ◽  
...  

1988 ◽  
Vol 67 (3-4) ◽  
pp. 275-294 ◽  
Author(s):  
Jerome J. Solomon ◽  
Frank Mukai ◽  
John Fedyk ◽  
Alvin Segal

Molecules ◽  
2018 ◽  
Vol 23 (9) ◽  
pp. 2291 ◽  
Author(s):  
David Malinak ◽  
Eugenie Nepovimova ◽  
Daniel Jun ◽  
Kamil Musilek ◽  
Kamil Kuca

The acetylcholinesterase (AChE) reactivators (e.g., obidoxime, asoxime) became an essential part of organophosphorus (OP) poisoning treatment, together with atropine and diazepam. They are referred to as a causal treatment of OP poisoning, because they are able to split the OP moiety from AChE active site and thus renew its function. In this approach, fifteen novel AChE reactivators were determined. Their molecular design originated from former K-oxime compounds K048 and K074 with remaining oxime part of the molecule and modified part with heteroarenium moiety. The novel compounds were prepared, evaluated in vitro on human AChE (HssAChE) inhibited by tabun, paraoxon, methylparaoxon or DFP and compared to commercial HssAChE reactivators (pralidoxime, methoxime, trimedoxime, obidoxime, asoxime) or previously prepared compounds (K048, K074, K075, K203). Some of presented oxime reactivators showed promising ability to reactivate HssAChE comparable or higher than the used standards. The molecular modelling study was performed with one compound that presented the ability to reactivate GA-inhibited HssAChE. The SAR features concerning the heteroarenium part of the reactivator’s molecule are described.


Sign in / Sign up

Export Citation Format

Share Document